ELIEM THERAPEUTICS INC (ELYM) Stock Balance Sheet
NASDAQ:ELYM - Nasdaq - US28658R1068 - Common Stock
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 43.59M | 46.92M | 20.49M | |||
| Cash Equivalents | 223.14M | 93.11M | 43.60M | 46.90M | 20.50M | |||
| Marketable Securities | 0.00 | 13.69M | 80.00M | 89.60M | N/A | |||
| Other Current Assets | 2.86M | 3.46M | 10.90M | 11.80M | 1.50M | |||
| Total Current Assets | 226.00M | 110.25M | 134.40M | 148.30M | 22.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 21.00K | 199.00K | 500.00K | N/A | N/A | |||
| Other Non-Current Assets | 0.00 | 15.00K | 100.00K | 25.00M | 2.60M | |||
| Total Non-Current Assets | 21.00K | 214.00K | 600.00K | 24.90M | 2.60M | |||
| TOTAL ASSETS | 226.02M | 110.47M | 135.00M | 173.20M | 24.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.13M | 2.77M | 5.30M | 4.60M | 1.20M | |||
| Accounts Payable | 610.00K | 66.00K | 800.00K | 1.40M | 1.30M | |||
| Other Current Liabilities | 0.00 | N/A | 0.00 | 0.00 | 600.00K | |||
| Total Current Liabilities | 3.74M | 2.83M | 6.10M | 6.00M | 3.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 37.00K | 200.00K | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 37.00K | 200.00K | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 3.74M | 2.87M | 6.30M | 6.00M | 3.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -212.56M | -155.98M | -120.90M | -75.60M | -28.10M | |||
| Additional Paid In Capital | 434.83M | 263.58M | 249.90M | 242.90M | 3.20M | |||
| Common Shares | 7.00K | 3.00K | 0.00 | 0.00 | 46.60M | |||
| Other Shareholders' Equity | 0.00 | -2.00K | -400.00K | -100.00K | N/A | |||
| Shares Outstanding | 66.79M | 27.70M | 26.60M | 26.20M | 25.40M | |||
| Tangible Book Value per Share | 3.33 | 3.88 | 4.84 | 6.38 | -0.98 | |||
| Total Shareholders' Equity | 222.28M | 107.60M | 128.70M | 167.20M | 21.60M | |||
| TOTAL LIABILITIES AND EQUITY | 226.02M | 110.47M | 135.00M | 173.20M | 24.60M | |||
| Statistics | ||||||||
| Current Ratio | 60.41 | 38.92 | 22.03 | 24.72 | 7.10 | |||
| Return On Assets (ROA) | -28.40% | -31.79% | -33.51% | -30.04% | -93.29% | |||
| Return On Equity (ROE) | -28.88% | -32.64% | -35.15% | -31.12% | -106.25% | |||
All data in USD , ROIC based on taxRate of 0.21